Oligonucleotide compositions and their use to induce apoptosis


Ontology type: sgo:Patent     


Patent Info

DATE

2011-02-22T00:00

AUTHORS

Nigel C. Phillips , Mario C. Filion , Zdenek Richard Holan , Stephanie Reader

ABSTRACT

The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Nigel C. Phillips", 
        "type": "Person"
      }, 
      {
        "name": "Mario C. Filion", 
        "type": "Person"
      }, 
      {
        "name": "Zdenek Richard Holan", 
        "type": "Person"
      }, 
      {
        "name": "Stephanie Reader", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1074/jbc.273.52.34992", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002417439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/taap.1997.8103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009474721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/14.20.8135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017813738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.92.20.9363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021293422"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/07328319908044830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023922241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.37.26369", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025318715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4157(94)90001-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031407168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4157(94)90001-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031407168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/372333a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031628023", 
          "https://doi.org/10.1038/372333a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.081560598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049150821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.13.5873", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053390529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00278a012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055168369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi970341y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055213652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi970341y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055213652"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-02-22T00:00", 
    "description": "

The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.

", "id": "sg:patent.US-7893242-B2", "keywords": [ "oligonucleotides", "apoptosis", "invention", "synthetic oligonucleotides", "sequence", "base", "DNA base", "hypoxanthine", "uracil", "guanine", "thymine", "method", "composition", "cell", "disease", "condition", "proliferation", "autoimmune disease", "lymphoproliferative disease", "inflammation", "Neoplasm" ], "name": "Oligonucleotide compositions and their use to induce apoptosis", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.450586.a", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7893242-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:06", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00167.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7893242-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7893242-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7893242-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7893242-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

92 TRIPLES      15 PREDICATES      47 URIs      29 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7893242-B2 schema:about anzsrc-for:3103
2 schema:author Ne54e39ec985e472ba1efb010738ca146
3 schema:citation sg:pub.10.1038/372333a0
4 https://doi.org/10.1006/taap.1997.8103
5 https://doi.org/10.1016/0304-4157(94)90001-9
6 https://doi.org/10.1021/bi00278a012
7 https://doi.org/10.1021/bi970341y
8 https://doi.org/10.1073/pnas.081560598
9 https://doi.org/10.1073/pnas.91.13.5873
10 https://doi.org/10.1073/pnas.92.20.9363
11 https://doi.org/10.1074/jbc.273.52.34992
12 https://doi.org/10.1074/jbc.274.37.26369
13 https://doi.org/10.1080/07328319908044830
14 https://doi.org/10.1093/nar/14.20.8135
15 schema:datePublished 2011-02-22T00:00
16 schema:description <p num="p-0001">The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.</p>
17 schema:keywords DNA base
18 Neoplasm
19 apoptosis
20 autoimmune disease
21 base
22 cell
23 composition
24 condition
25 disease
26 guanine
27 hypoxanthine
28 inflammation
29 invention
30 lymphoproliferative disease
31 method
32 oligonucleotides
33 proliferation
34 sequence
35 synthetic oligonucleotides
36 thymine
37 uracil
38 schema:name Oligonucleotide compositions and their use to induce apoptosis
39 schema:recipient https://www.grid.ac/institutes/grid.450586.a
40 schema:sameAs https://app.dimensions.ai/details/patent/US-7893242-B2
41 schema:sdDatePublished 2019-04-18T10:06
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher Na52cfd9101944f1a9462b3ab831ff441
44 sgo:license sg:explorer/license/
45 sgo:sdDataset patents
46 rdf:type sgo:Patent
47 N1bfe4d3fa6014a6785ac6bc407a0ef6e rdf:first Nb42460f8fffb4646823a6a966802fcdf
48 rdf:rest rdf:nil
49 N1ef33d54c90f4d63a01579d122297b9d schema:name Nigel C. Phillips
50 rdf:type schema:Person
51 N2af447013a6f49d1b5fc2a26b6bcb297 rdf:first Ndf38d1967d1044048c82efbdd6e05b5a
52 rdf:rest N47c4e0a451e44f5386c7655c2853d175
53 N2e6eea0cd73248f99e8a102d06ce4d24 schema:name Zdenek Richard Holan
54 rdf:type schema:Person
55 N47c4e0a451e44f5386c7655c2853d175 rdf:first N2e6eea0cd73248f99e8a102d06ce4d24
56 rdf:rest N1bfe4d3fa6014a6785ac6bc407a0ef6e
57 Na52cfd9101944f1a9462b3ab831ff441 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 Nb42460f8fffb4646823a6a966802fcdf schema:name Stephanie Reader
60 rdf:type schema:Person
61 Ndf38d1967d1044048c82efbdd6e05b5a schema:name Mario C. Filion
62 rdf:type schema:Person
63 Ne54e39ec985e472ba1efb010738ca146 rdf:first N1ef33d54c90f4d63a01579d122297b9d
64 rdf:rest N2af447013a6f49d1b5fc2a26b6bcb297
65 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
66 rdf:type schema:DefinedTerm
67 sg:pub.10.1038/372333a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031628023
68 https://doi.org/10.1038/372333a0
69 rdf:type schema:CreativeWork
70 https://doi.org/10.1006/taap.1997.8103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009474721
71 rdf:type schema:CreativeWork
72 https://doi.org/10.1016/0304-4157(94)90001-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031407168
73 rdf:type schema:CreativeWork
74 https://doi.org/10.1021/bi00278a012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055168369
75 rdf:type schema:CreativeWork
76 https://doi.org/10.1021/bi970341y schema:sameAs https://app.dimensions.ai/details/publication/pub.1055213652
77 rdf:type schema:CreativeWork
78 https://doi.org/10.1073/pnas.081560598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049150821
79 rdf:type schema:CreativeWork
80 https://doi.org/10.1073/pnas.91.13.5873 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053390529
81 rdf:type schema:CreativeWork
82 https://doi.org/10.1073/pnas.92.20.9363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021293422
83 rdf:type schema:CreativeWork
84 https://doi.org/10.1074/jbc.273.52.34992 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002417439
85 rdf:type schema:CreativeWork
86 https://doi.org/10.1074/jbc.274.37.26369 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025318715
87 rdf:type schema:CreativeWork
88 https://doi.org/10.1080/07328319908044830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023922241
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1093/nar/14.20.8135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017813738
91 rdf:type schema:CreativeWork
92 https://www.grid.ac/institutes/grid.450586.a schema:Organization
 




Preview window. Press ESC to close (or click here)


...